You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BEAM Exercise Disclosure
Evans John M. · SEC Form 4 · Filed Jul 1, 2026
Exercise
Calculated transaction value
$25.75K
Evans John M. CEO
BEAM
Transaction date
Jun 30, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 1 day later
BEAM daily price context
Close on/before transaction
$34.32
Jun 30, 2026
First close after public filing
$34.79
Jul 2, 2026
30-day return after filing
-26.65%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 25,000 shares @ $1.03
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-292526
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$1.79M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Beam Therapeutics Inc. BEAM Current | Exercise | Jun 30, 2026 | $25.75K |
| Beam Therapeutics Inc. BEAM | Sale | Jun 30, 2026 | $791.48K |
| Beam Therapeutics Inc. BEAM | Exercise | Jun 30, 2026 | $0 |
| Beam Therapeutics Inc. BEAM | Sale | Jun 30, 2026 | $66.2K |
| Beam Therapeutics Inc. BEAM | Exercise | Jun 29, 2026 | $0 |
| Beam Therapeutics Inc. BEAM | Exercise | Jun 29, 2026 | $12.5K |
| Beam Therapeutics Inc. BEAM | Exercise | Jun 29, 2026 | $6.53K |
| Beam Therapeutics Inc. BEAM | Sale | Jun 29, 2026 | $471.53K |
| Beam Therapeutics Inc. BEAM | Sale | Jun 29, 2026 | $415.82K |
| Beam Therapeutics Inc. BEAM | Exercise | Jun 29, 2026 | $0 |